Clovis Oncology Inc (NASDAQ:CLVS)

0.6899
Delayed Data
As of May 27
 +0.0157 / +2.33%
Today’s Change
0.61
Today|||52-Week Range
7.24
-74.54%
Year-to-Date
2 Biotech Stocks That Could Go Parabolic
May 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close0.67
Today’s open0.70
Day’s range0.62 - 0.70
Volume214,457
Average volume (3 months)9,833,179
Market cap$104.7M
Data as of 4:50pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)+47.72%
Earnings growth (this year)+27.37%
Earnings growth (next 5 years)+40.19%
Revenue growth (last year)-9.58%
P/E ratioNM
Price/Sales2.10
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DAREDare Bioscience Inc0.000.00%
TBGNFOxurion NV0.000.00%
FBIOFortress Biotech Inc+0.05+6.47%
PRTKParatek Pharmaceutic...+0.07+3.91%
Data as of 4:00pm ET, 05/27/2022

Financials

Next reporting dateAugust 3, 2022
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$148.8M
Annual profit (last year)-$264.5M
Net profit margin-177.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Boulder, Colorado

Forecasts